Cancer Type/Condition: Lymphoma, Hodgkin lymphoma, child
Stage/Subtype: stage III childhood Hodgkin lymphoma
Country: U.S.A.
Trial Type: Treatment
Trial Status: Active
1.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: NCI
Protocol IDs: COG-AHOD0831, AHOD0831, NCT01026220
|
|
2.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: MSKCC-95024, NCI-V95-0685, NCT00002663
|
|
3.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 70 and under
Sponsor: Other
Protocol IDs: BCM-H-19386, BCM-FAB, H 19386, NCT00625144
|
|
4.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 0 to 55
Sponsor: Other
Protocol IDs: 8717, NCT00673114
|
|
5.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 1 to 17
Sponsor: Pharmaceutical / Industry
Protocol IDs: AP23573-07-110, SUN08-01, NCT00704054
|
|
6.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 74
Sponsor: NCI
Protocol IDs: 080051, 08-C-0051, NCT00923910
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: PSCI-2003-232, NCT00084695
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 70 years and younger
Sponsor: NCI
Protocol IDs: OHSU-HEM-04083-L, OHSU-IRB-248, NCT00238433
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Under 70
Sponsor: NCI
Protocol IDs: UMN-2001LS058, UMN-MT2001-10, NCT00303719
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Under 70
Sponsor: NCI
Protocol IDs: UMN-2005LS036, UMN-MT-2005-02, UMN-0507M70121, NCT00305682
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: HOD99, NCT00145600
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Under 70
Sponsor: NCI
Protocol IDs: UMN-2005LS048, UMN-0508M72589, UMN-MT2004-24, NCT00345865
|
|
13.
|
Phase: Phase II
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: HOD05, NCT00352027
|
|
14.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 70 years old and under
Sponsor: NCI
Protocol IDs: CCCWFU-29506, CCCWFU 29506, NCT00453206, CCCWFU-IRB00001366
|
|
15.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Any age
Sponsor: NCI
Protocol IDs: CINJ-3330, NCT00161187
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 13 to 65
Sponsor: NCI
Protocol IDs: MSKCC-07147, 07-147, NCT00574496
|
|
17.
|
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 2 and over
Sponsor: NCI
Protocol IDs: CHNMC-06141, 06141, NCT00589563
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: 2007-0144, NCT00654732
|
|
19.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 11300A, NCT00683046
|
|
20.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 70 and under
Sponsor: NCI, Other
Protocol IDs: BMT136, 78998, BMT153, NCT00185640, PO1 CA49605, NCT00186615
|
|
21.
|
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: CDR0000630617, BMTGG-NSH-756, NCT00818961
|
|
22.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 6 and over
Sponsor: Other
Protocol IDs: UFPTI 0806 - HL01, NCT00850200
|
|
23.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 1 to 70
Sponsor: NCI, NHLBI
Protocol IDs: 606, U01 HL069294, NCT00864227
|
|
24.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 3 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: P2 L-D AB, NCT00917826
|
|
25.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 0 to 65
Sponsor: Other
Protocol IDs: 2009-0266, NCT01010217
|
